RNS Number:1293V
Cambridge Antibody Tech Group PLC
05 December 2005
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
JOHN ASTON
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
338
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
60,300
0.114%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
30 DECEMBER 2008 TO 29 DECEMBER 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
25,742 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 PENCE PER SHARE SUBJECT TO AWARD
22. Total number of shares or debentures over which options held following
notification
143,568 OF WHICH:
44,180 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
82,507 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
16,881 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
NIGEL BURNS
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
294
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
3,554
0.0067%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
30 DECEMBER 2008 TO 29 DECEMBER 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
10,095 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 PENCE PER SHARE SUBJECT TO AWARD
22. Total number of shares or debentures over which options held following
notification
83,773 OF WHICH:
54,723 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
29,050 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
PETER CHAMBRE
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
352
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
26,442
0.050%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
30 DECEMBER 2008 TO 29 DECEMBER 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
52,511 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 PENCE PER SHARE SUBJECT TO AWARD
22. Total number of shares or debentures over which options held following
notification
381,072 OF WHICH:
191,969 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
145,021 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
44,082 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
ALEXANDER DUNCAN
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
323
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
14,439
0.027%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
30 DECEMBER 2008 TO 29 DECEMBER 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
11,441 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 PENCE PER SHARE SUBJECT TO AWARD
22. Total number of shares or debentures over which options held following
notification
64,803 OF WHICH:
31,776 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
29,640 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
3,387 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
JUSTIN HOSKINS
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
294
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
2,460
0.0046%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
2 DECEMBER 2008 TO 1 DECEMBER 2015 SUBJECT TO PERFORMANCE CONDITION
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
3,930 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
#6.84 PENCE PER SHARE SUBJECT TO PERFORMANCE CONDITION
22. Total number of shares or debentures over which options held following
notification
11,764 OPTIONS UNDER COMPANY SHARE OPTION PLAN
23. Any additional information
NONE
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
LYNN LESTER
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
323
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
2,424
0.0046%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
30 DECEMBER 2008 TO 29 DECEMBER 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
7,704 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 PENCE PER SHARE SUBJECT TO AWARD
22. Total number of shares or debentures over which options held following
notification
24,906 OF WHICH:
12,361 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
10,421 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
2,124 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
RICHARD MASON
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
308
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
3,262
0.0062%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
(1) 2 DECEMBER 2005
(2) 2 DECEMBER 2005
18. Period during which or date on which it can be exercised
(1) 30 DECEMBER 2008 TO 29 DECEMBER 2011
(2) 2 DECEMBER 2008 TO 1 DECEMBER 2015
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
(1) 3,036 ORDINARY 10 PENCE SHARES
(2) 9,137 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
(1) 10 PENCE PER SHARE SUBJECT TO AWARD
(2) #6.84 PER SHARE SUBJECT TO PERFORMANCE CONDITION
22. Total number of shares or debentures over which options held following
notification
45,138 OF WHICH:
39,958 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
5,180 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
DIANE MELLETT
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
308
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
18,271
0.035%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
30 DECEMBER 2008 TO 29 DECEMBER 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
19,207 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 PENCE PER SHARE SUBJECT TO AWARD
22. Total number of shares or debentures over which options held following
notification
118,423 OF WHICH:
63,304 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
51,108 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
4,011 ARE MATCHING SHARES UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required
by DR 3.1.4R(1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and
24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC
2. State whether the notification relates to (i) a transaction notified in
accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as
extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
(ii)
3. Name of person discharging managerial responsibilities/director
PATRICK ROUND
4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person
AS IN 3 ABOVE
5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect of a non-beneficial interest
AS IN 3 ABOVE
6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares
ORDINARY 10 PENCE SHARES
7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them
COMPUTERSHARE TRUSTEES LIMITED
8 State the nature of the transaction
ALLOCATION OF FREESHARES UNDER INLAND REVENUE APPROVED SHARE INCENTIVE PLAN
9. Number of shares, debentures or financial instruments relating to shares
acquired
294
10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when calculating percentage)
0.0006%
11. Number of shares, debentures or financial instruments relating to shares
disposed
NIL
12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when calculating percentage)
NIL
13. Price per share or value of transaction
#6.80
14. Date and place of transaction
1 DECEMBER 2005
LONDON
15. Total holding following notification and total percentage holding following
notification (any treasury shares should not be taken into account when
calculating percentage)
294
0.0006%
16. Date issuer informed of transaction
1 DECEMBER 2005
If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes
17 Date of grant
2 DECEMBER 2005
18. Period during which or date on which it can be exercised
30 DECEMBER 2008 TO 29 DECEMBER 2011
19. Total amount paid (if any) for grant of the option
NIL
20. Description of shares or debentures involved (class and number)
11,557 ORDINARY 10 PENCE SHARES
21. Exercise price (if fixed at time of grant) or indication that price is to be
fixed at the time of exercise
10 PENCE PER SHARE SUBJECT TO AWARD
22. Total number of shares or debentures over which options held following
notification
55,466 OF WHICH:
5,725 ARE OPTIONS UNDER COMPANY SHARE OPTION PLAN
49,741 ARE RESTRICTED SHARE AWARDS UNDER EXECUTIVE INCENTIVE PLAN
23. Any additional information
AWARDS GRANTED UNDER THE EXECUTIVE INCENTIVE PLAN ARE SUBJECT TO PERFORMANCE
CONDITIONS
24. Name of contact and telephone number for queries
JUSTIN HOSKINS
01223 898589
Name and signature of duly authorised officer of issuer responsible for making
notification
JUSTIN HOSKINS
COMPANY SECRETARY
Date of notification
2 DECEMBER 2005
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSILFFLFFLEIIE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
